A multifunctional nanostructured platform for localized sustained release of analgesics and antibiotics

European Journal of Pain Supplements

Volumn 5, Issue 2, 2011, Pages 423-432

  Murphy, Matthew B ^a   Khaled, S M ^a   Fan, Dongmei ^a   Yazdi, Iman K ^a,b   Sprintz, Michael ^a,c   Buchanan, Rachel M ^a,d   Smid, Christine A ^a,d   Weiner, Bradley K ^a   Ferrari, Mauro ^a   Tasciotti, Ennio ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF HOUSTON   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d The University of Texas at Austin   (United States)

Author keywords

Controlled release; Drug delivery; Nanomedicine; Platelet rich plasma

Indexed keywords

BUPIVACAINE; CEFAZOLIN; DEXAMETHASONE; NANOPARTICLE; POLYGLACTIN; SILICON DIOXIDE;

ANIMAL EXPERIMENT; ARTICLE; BIOCOMPATIBILITY; HOSPITAL COST; HOSPITALIZATION; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; LENGTH OF STAY; MALE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SUSTAINED DRUG RELEASE; THROMBOCYTE RICH PLASMA;

EID: 83355177380     PISSN: 17543207     EISSN: 18780075     Source Type: Journal    
DOI: 10.1016/j.eujps.2011.08.002     Document Type: Article

References (27)

1. Al Malyan M., Becchi C., Nikkola L., Viitanen P., Boncinelli S., Chiellini F., et al. Polymer-based biodegradable drug delivery systems in pain management. J Craniofac Surg 2006, 17:302-313.
2. Bratzler D.W., Houck P.M., Richards C., Steel L., Dellinger P., Fry D.E., et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg 2005, 140:174-182.
3. Brennan T.J., Umali E.F., Zahn P.K. Comparison of pre- versus post-incision administration of intrathecal bupivacaine and intrathecal morphine in a rat model of postoperative Pain. Anesthesiology 1997, 87(6):1517-1528.
4. Centers for Disease Control and Prevention, National Center for Health Statistics Vital and Health Statistics. Detailed diagnoses and procedures national hospital discharge survey 1994, vol. 127. Hyattsville (MD): Department of Health and Human Services; 1997.
5. Curley J., Castillo J., Hotz J., Uezono M., Hernandez S., Lim J.O., et al. Prolonged regional nerve blockade: injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996, 84(6):1401-1410.
6. Gravel D., Taylor G., Ofner M., Johnston L., Loeb M., Roth V.R., et al. Point prevalence survey for healthcare-associated infections within Canadian adult acute-care hospitals. J Hosp Infect 2007, 66:243-248.
7. Haley R.W., Culver D.H., White J.W., Morgan W.M., Emori T.G. The nationwide nosocomial infection rate: a new need for vital statistics. Am J Epidemiol 1985, 121:159-167.
8. Hickey T., Kreutzer D., Burgess D.J., Moussy F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002, 23:1649-1656.
9. Kim D.H., Martin D.C. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 2006, 27:3031-3037.
10. Lallemand S., Thouverez M., Bailly P., Bertrand X., Talon D. Non-observance of guidelines for surgical antimicrobial prophylaxis and surgical-site infections. Pharm World Sci 2002, 24:95-99.
11. Le Corre P., Estebe J.P., Clement R., Du Plessis L., Chevanne F., Ecoffey C., et al. Spray-dried bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep. Int J Pharm 2002, 238:191-203.
12. Mainardes R.M., Evangelista R.C. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm 2005, 290:137-144.
13. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Am J Infect Control 1999, 27:97-132.
14. Mooren R.E., Hendriks E.J., van den Beucken J.J., Merkx M.A., Meijer G.J., Jansen J.A., et al. The effect of platelet-rich plasma in vitro on primary cells: rat osteoblast-like cells and human endothelial cells. Tissue Eng A 2010, 16(10):3159-3172.
15. Murphy M.B., Blashki D., Buchanan R.M., Fan D., DeRosa E., Shah R.N., et al. Multi-composite bioactive osteogenic sponges featuring mesenchymal stem cells, platelet-rich plasma, nanoporous silicon enclosures, and peptide amphiphiles for rapid bone regeneration. J Funct Biomater 2011, 2(2):39-66.
16. Murphy MB, Blashki D, Buchanan RM, Yazdi IK, Ferrari M, Simmons PJ, et al. Characterization of umbilical cord blood-derived and adult platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Stem Cells, submitted for publication.
17. Nichols R.L. Postoperative infections in the age of drug-resistant gram-positive bacteria. Am J Med 1998, 104:11S-16S.
18. Park E.S., Maniar M., Shah J.C. Biodegradable polyanhydride devices of cefazolin sodium, bupivacaine, and taxol for local drug delivery: preparation, and kinetics and mechanism of in vitro release. J Cont Release 1998, 52:179-189.
19. Pellizzer G., Mantoan P., Timillero L., Allegranzi B., Fedeli U., Schievano E., et al. Prevalence and risk factors for nosocomial infections in hospitals of the Veneto region, north-eastern Italy. Infection 2008, 36:112-119.
20. Reilly J., Stewart S., Allardice G.A., Noone A., Robertson C., Walker A., et al. Results from the Scottish National HAI Prevalence Survey. J Hosp Infect 2008, 69:62-68.
21. Sampson S., Gerhardt M., Mandelbaum B. Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 2008, 1(3-4):165-174.
22. Slowing I.I., Vivero-Escoto J.L., Wu C.W., Lin V.S.Y. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Del Rev 2008, 60:1278-1288.
23. Stratchounski L.S., Taylor E.W., Dellinger E.P., Pechere J.C. Antibiotic policies in surgery: a consensus paper. Int J Antimicrob Agents 2005, 26:312-322.
24. Tourmousoglou C.E., Yiannakopoulou E., Kalapothaki V., Bramis J., St. Papadopoulos J. Adherence to guidelines for antibiotic prophylaxis in general surgery: a critical appraisal. J Antimicrob Chemother 2008, 61:214-218.
25. White P.F., Kehlet H. Improving postoperative pain management: what are the unresolved issues?. Anesthesiology 2010, 112:220-225.
26. Zahn P.K., Brennan T.J. Primary and secondary hyperalgesia in a rat model for human postoperative pain. Anesthesiology 1999, 90(3):863-872.
27. Zolnik B.S., Burgess D.J. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Cont Release 2008, 127:137-145.